Psp Invests In Telecommunications, Cppib In Biopharmaceuticals
The Public Sector Pension Investment Board is entering a definitive agreement with Loral Space & Communications Inc. and Telesat Canada to combine the two telecommunications businesses into a new Canadian public company. The PSP will own a 36.7 per cent interest in New Telesat as a result of the merger, expected to close in the ...
Off And Racing To A Carefree Retirement
An indexed-guaranteed pension is a better option than gambling with your future retirement. : I am aged 59, married and thinking of retiring in a year or two. My defined-benefit with Unisuper is about $1.2 million. My main concern is what choice to make the day I decide to retire: take up Unisuper's indexed-linked pension, select its Flexi-pension scheme or go to the races and make friends with some bookies.
Trove Raises $16M Series A Led By Andreessen Horowitz, Unveils Rebrand To Pave
Announces Launch Of Pave Compensation Benchmarking Project -- The First-Ever API-Powered Compensation Data Survey With Exclusive Group Of Top VC Firms SAN FRANCISCO, December 3, 2020-- Trove, which provides a suite of real-time total compensation tools, announced today that it raised $16 million in Series A funding led by Andreessen Horowitz (a16z) and unveiled its rebrand to Pave. a16z Cultural Leadership Fund, Bessemer Venture Partners, Bezos Expeditions (a personal investment company of Jeff Bezos), Dash Fund, and Y Combinator participated in the oversubscribed round.
Canada Joins Philip Low's Neurovigil Conglomerate
PALO ALTO, Calif. & WATERLOO, Ontario--(BUSINESS WIRE)--Silicon Valley-based neurotech intellectual property powerhouse NeuroVigil, and the University of Waterloo, Silicon Valley's largest international supplier of tech talent, announced today they have signed an agreement clearing the way for University of Waterloo's formal membership in NeuroVigil's conglomerate, headed by Philip Low, NeuroVigil's Chairman, CEO and Founder. The signing marks the formal international launch of Dr. Low's vision.
Scale Venture Partners Announces Close Of New $600M Fund
Oversubscribed fund continues firm's focus on enterprise software including security, cloud infrastructure, and "Cognitive Apps" FOSTER CITY, Calif., December 3, 2020-- Scale Venture Partners today announced that it has closed Scale Venture Partners Fund VII with $600 million in committed capital. The fund, which was strongly supported by existing and new investors, continues the firm's strategy of investing in cloud and SaaS software companies that are transforming how enterprises work. Scale's previous fund, the $400 million Fund VI, closed in July 2018.
Nuburu Completes $20M Series B Funding Round To Expand Market Leadership In Blue Wavelength Industrial Lasers
NUBURU Completes $20 Million Series B Funding Round to Expand Market Leadership in Blue Wavelength Industrial Lasers With its largest financing round to date and two new senior business advisors on its board of directors, NUBURU is primed to increase adoption of its disruptive, proprietary blue laser technology CENTENNIAL, Colo., December 3, 2020-- NUBURU, the leader in high power blue laser technology, today announced that it has raised $20 million in Series B funding to accelerate development of its high brightness AI(tm) Series industrial product line and to expand its presence in the energy storage, e-mobility and 3D printing markets.
Novakid Raises $4.25M In Series A Financing To Reinvent Online Esl Learning For Kids
SAN FRANCISCO, Calif., December 3, 2020-- Novakid Inc, an emerging EdTech brand reinventing learning English as a second language for children ages 4-12, announces today the closing of a $4.25 million Series A financing from a group of US, Asia and Europe-based investors. The financing round is led by a Hungary-based PortfoLion (part of OTP, a leading banking group in Eastern Europe) and joined by a prominent EdTech-focused US fund LearnStart (part of LearnCapital VC family, which backed a number of notable EdTech-companies, among them VIPKID and Brilliant.org), as well as renowned firms TMT Investments and Xploration Capital.
Rubedo Life Sciences Closes $12M Seed Financing Led By Khosla Ventures
- Company optimizing lead compounds to file IND application and initiate first-in-human clinical trials targeting senescent cells in pulmonary disorders - Funding will be used to drive R&D, advance clinical pipeline and expand scientific team SUNNYVALE, Calif., December 3, 2020-- Rubedo Life Sciences, a biopharmaceutical company committed to developing first-in-class therapies targeting senescent cells which drive age-related diseases, today announced the closing of a $12M Seed financing round. The round was led by Khosla Ventures, with participation from Longevity Fund, Refactor Capital, Shanda and additional investors.
Sourcegraph Secures $50M In Series C Funding For Universal Code Search
Universal Code Search Empowers Developers to Tackle Challenges of Big Code; Andrew Reed of Sequoia Joins Board of Directors SAN FRANCISCO, December 3, 2020-- Sourcegraph, the leader in Universal Code Search, announced today that it has secured $50 million in Series C funding led by Sequoia Capital. Sourcegraph will use the new funds to address the increasing demand for Universal Code Search, empowering developers to better manage the challenges of Big Code. Sourcegraph also announced that Andrew Reed, partner at Sequoia, has joined the company's Board of Directors.
Pave, Formerly Trove, Receives $16M Series A Led By Andreessen Horowitz
Pave, Formerly Trove, Receives $16 Million Series A led by Andreessen Horowitz Crowdfund Insider. : Pave, formerly named Trove and recently rebranded, has received $16 million in an oversubscribed Series A funding round led by Andreessen Horowitz. Other big names participated in the round including Bessemer Venture Partners, Bezos Expeditions (as in Jeff Bezos), Dash Fund, and Y Combinator. Kristina Shen, General Partner, a16z, will join Pave's board of directors, and Marc Andreessen will be a board observer. Pave also announced plans to launch the Pave Compensation Benchmarking Project this week -- a compensation data survey.
Bioage Raises $90M To Treat Aging And Age-related Diseases
Proceeds will support advancement of the company's pipeline and proprietary platform for identifying and developing therapies to treat diseases of aging Company announces Chief Medical Officer as it prepares to enter clinic in 2021 with lead Phase 2-ready therapeutic compounds RICHMOND, Calif., December 3, 2020-- BioAge Labs, Inc., a biotechnology company developing medicines to treat aging and aging-related diseases, today announced that it has raised $90 million in an oversubscribed Series C financing.